Pharmavite acquires urinary health brand Uqora

Pharmavite said the acquisition of four-year-old Uqora was meant to strengthen its position in the women’s health market, where it already sells the menopause-focused Equelle brand.
David Salazar
Managing Editor
David Salazar profile picture

Vitamin and supplement maker Pharmavite is adding to its brand portfolio with the acquisition of Uqora, a company focused on urinary health. Pharmavite, which makes the Nature Made brand, said the acquisition of the four-year-old company was meant to strengthen its position in the women’s health market, where it sells the menopause-focused Equelle brand, noting that Uqora has seen triple-digit growth since its launch. 

“Uqora’s science-based approach to addressing women’s urinary health issues aligns perfectly with our 50-year history of offering high-quality science-based products,” said Jeff Boutelle, CEO of Pharmavite. “Uqora plays a central role in our long-term strategy to offer the most comprehensive women’s health platform in the vitamin, mineral and supplement industry and alongside our existing Equelle brand, furthers our commitment to innovating in the under-served women’s health market.” 

Pharmavite said urinary tract infections are the second-most common infection in the United States behind the common cold, with a disproportionate impact on women. Uqora offers pro-active urinary health products Target, Control and Promote, as well as medical devices and drugs for identifying and treating UTIs under the names Clarify, Combat and Soothe. 

“This is an exciting moment for me, [co-founder Spencer Gordon] and the Uqora team — this acquisition means we now have access to resources from a leader in the health and wellness space who can help us further our research efforts and accelerate our ability to develop new products,” said Jenna Ryan, CEO and co-founder of Uqora. “Our goal has always been to make our products available to every person who needs them. With Pharmavite, we know we can bring that vision to life” 

Pharmavite said that following the acquisition, which closed July 1, Uqora will keep operating from San Diego with the co-founders and its current team in place. 

“This is an important moment at Pharmavite that underscores our commitment to women’s health. Through research and development, new product innovation and potential further acquisition, we are focused on making long-term investments in providing better solutions for women to proactively manage their own health and wellness,” said Tobe Cohen, Pharmavite's chief growth officer.